XNK Therapeutics has announced that Ted Fjällman, Partner at Flerie Invest, has joined the company’s board of directors.
Flerie Invest led the SEK 132 million financing of XNK earlier this year by placing SEK 100 million and thus gaining approximately 22 percent of the total number of shares a